Diagnostics (Jul 2021)

Brain Tissue Low-Level Mosaicism for <i>MTOR</i> Mutation Causes Smith–Kingsmore Phenotype with Recurrent Hypoglycemia—A Novel Phenotype and a Further Proof for Testing of an Affected Tissue

  • Krzysztof Szczałuba,
  • Małgorzata Rydzanicz,
  • Anna Walczak,
  • Joanna Kosińska,
  • Agnieszka Koppolu,
  • Anna Biernacka,
  • Katarzyna Iwanicka-Pronicka,
  • Wiesława Grajkowska,
  • Elżbieta Jurkiewicz,
  • Paweł Kowalczyk,
  • Rafał Płoski

DOI
https://doi.org/10.3390/diagnostics11071269
Journal volume & issue
Vol. 11, no. 7
p. 1269

Abstract

Read online

De novo somatic variants in genes encoding components of the PI3K–AKT3–mTOR pathway, including MTOR, have been linked to hemimegalencephaly or focal cortical dysplasia. Similarly to other malformations of cortical development, this condition presents with developmental delay and intractable epilepsy, often necessitating surgical treatment. We describe a first patient with the Smith–Kingsmore syndrome phenotype with recurrent hypoglycemia caused by low-level mosaic MTOR mutation restricted to the brain. We provide discussion on different aspects of somatic mosaicism. Deep exome sequencing combined with a variant search in multiple tissues and careful phenotyping may constitute a key to the diagnosis of the causes of rare brain anomalies.

Keywords